DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.compose your message
message sent
email sent successfully
Trusted Resources: News & Events
Latest announcements and gatherings
Howard University College of Medicine Receives Grant to Support Youth With Sickle Cell Disease
The Department of Pediatrics and Child Health in the Howard University College of Medicine has received a $42,000 grant from the Walter Brownley Trust Bank of America, N.A., Trustee to support children with sickle cell disease and their families. There are approximately 1,500 children and youth with sickle cell disease in the Washington, D.C. region.
The project supported by the grant, entitled “LIFE (Learning Is Fundamental for Everyone) with Sickle Cell Disease,” will focus on increasing educational and other support services for school-age children with sickle cell. Services include education and advocacy training, transportation assistance, special informational workshops for families, and distribution of other needed resources.
“Most sickle cell disease patients have low socioeconomic status, lack social support, and face many barriers for achieving optimal medical care and educational achievement,” says Dr. Sohail Rana, professor of pediatrics in the College of Medicine and lead administrator of the “Life” project.
Related Content
-
education & researchPhase 3 Study of L-Glutamine Therapy in Sickle Cell Anemia and Sickle ß0-Thalassemia Subgroup Analyses Show Consist...Background: Sickle cell disease (SCD) is...
-
news & eventsSCDAA News Advisory: SCDAA Statement on Exa-cel Gene TherapyOn October 31, 2023, the Food and Drug A...
-
education & researchRisk Factors for 30-Day Readmission in Adults with Sickle Cell DiseaseBACKGROUND: Readmission to the hospital...
-
people & placesKeith Quirolo, MDDr. Keith Quirolo is a pediatrician in O...
-
videos & visualsMy Red Cell Exchangehttps://www.youtube.com/watch?v=HTcLwgLE...
-
news & eventsPhase 3 Trial of Rivipansel in Treating SCD Pain Crisis Fails to Meet Goals, Pfizer AnnouncesThe Phase 3 RESET trial testing the effe...
-
people & placesVence L. Bonham, Jr, JDVence Bonham received his bachelor of Ar...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.